

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 4.35685350 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 4.33860214 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.25633546 |
| 4 | hemidesmosome assembly (GO:0031581) | 4.01953828 |
| 5 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.94473088 |
| 6 | vocalization behavior (GO:0071625) | 3.81608556 |
| 7 | gamma-aminobutyric acid transport (GO:0015812) | 3.78207933 |
| 8 | response to peptidoglycan (GO:0032494) | 3.77466265 |
| 9 | synaptic vesicle maturation (GO:0016188) | 3.70758292 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.53752495 |
| 11 | glycosphingolipid catabolic process (GO:0046479) | 3.52894925 |
| 12 | glutamate secretion (GO:0014047) | 3.51001959 |
| 13 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.50921912 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.49541396 |
| 15 | neuronal action potential propagation (GO:0019227) | 3.47907391 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 3.45855419 |
| 17 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.44878902 |
| 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.44604891 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43080580 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 3.43080580 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43080580 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43080580 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43080580 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 3.43080580 |
| 25 | locomotory exploration behavior (GO:0035641) | 3.43070228 |
| 26 | positive regulation of leukocyte degranulation (GO:0043302) | 3.41762856 |
| 27 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.40465975 |
| 28 | desmosome organization (GO:0002934) | 3.40281486 |
| 29 | synaptic vesicle exocytosis (GO:0016079) | 3.35219080 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.34029897 |
| 31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.32670984 |
| 32 | muscle filament sliding (GO:0030049) | 3.32651938 |
| 33 | actin-myosin filament sliding (GO:0033275) | 3.32651938 |
| 34 | hypotonic response (GO:0006971) | 3.31314403 |
| 35 | regulation of synapse structural plasticity (GO:0051823) | 3.31050576 |
| 36 | glycolipid catabolic process (GO:0019377) | 3.21118860 |
| 37 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.18248768 |
| 38 | regulation of synaptic vesicle transport (GO:1902803) | 3.17584179 |
| 39 | layer formation in cerebral cortex (GO:0021819) | 3.17583660 |
| 40 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.17111674 |
| 41 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.14451683 |
| 42 | neuron recognition (GO:0008038) | 3.13283856 |
| 43 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.08835372 |
| 44 | cellular potassium ion homeostasis (GO:0030007) | 3.07896247 |
| 45 | protein localization to synapse (GO:0035418) | 3.07792911 |
| 46 | toxin transport (GO:1901998) | 3.07202605 |
| 47 | iron ion import (GO:0097286) | 3.06324382 |
| 48 | intestinal epithelial cell development (GO:0060576) | 3.04617547 |
| 49 | protein localization to endosome (GO:0036010) | 3.02560019 |
| 50 | L-amino acid import (GO:0043092) | 3.02482676 |
| 51 | actin-mediated cell contraction (GO:0070252) | 3.01535868 |
| 52 | skin morphogenesis (GO:0043589) | 3.00075554 |
| 53 | cell adhesion mediated by integrin (GO:0033627) | 2.98768620 |
| 54 | glutamate receptor signaling pathway (GO:0007215) | 2.98413771 |
| 55 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.97780613 |
| 56 | regulation of water loss via skin (GO:0033561) | 2.97494932 |
| 57 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.95448516 |
| 58 | axonal fasciculation (GO:0007413) | 2.95200176 |
| 59 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.94878108 |
| 60 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.93888169 |
| 61 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93446616 |
| 62 | nucleobase catabolic process (GO:0046113) | 2.93207617 |
| 63 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.92972021 |
| 64 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.92845009 |
| 65 | neurotransmitter secretion (GO:0007269) | 2.90259547 |
| 66 | ceramide catabolic process (GO:0046514) | 2.90141183 |
| 67 | cerebellar granule cell differentiation (GO:0021707) | 2.90112015 |
| 68 | sodium ion export (GO:0071436) | 2.89434776 |
| 69 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.88408416 |
| 70 | dendritic spine morphogenesis (GO:0060997) | 2.87699440 |
| 71 | cellular polysaccharide catabolic process (GO:0044247) | 2.87635400 |
| 72 | response to muscle activity (GO:0014850) | 2.85122232 |
| 73 | glucan catabolic process (GO:0009251) | 2.82135870 |
| 74 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.81568889 |
| 75 | synaptic transmission, glutamatergic (GO:0035249) | 2.80891417 |
| 76 | cellular extravasation (GO:0045123) | 2.80655259 |
| 77 | dendrite morphogenesis (GO:0048813) | 2.78350811 |
| 78 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.77580495 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 2.76462258 |
| 80 | detection of external biotic stimulus (GO:0098581) | 2.75671666 |
| 81 | membrane lipid catabolic process (GO:0046466) | 2.75363263 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 2.75265024 |
| 83 | skeletal muscle contraction (GO:0003009) | 2.75118679 |
| 84 | negative regulation of lipid storage (GO:0010888) | 2.74904144 |
| 85 | glycogen catabolic process (GO:0005980) | 2.74571184 |
| 86 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.73556907 |
| 87 | sphingolipid catabolic process (GO:0030149) | 2.72922645 |
| 88 | establishment of skin barrier (GO:0061436) | 2.72275352 |
| 89 | neuromuscular process controlling balance (GO:0050885) | 2.71566565 |
| 90 | early endosome to late endosome transport (GO:0045022) | 2.71127587 |
| 91 | neutrophil activation involved in immune response (GO:0002283) | 2.70854962 |
| 92 | macrophage activation (GO:0042116) | 2.70283021 |
| 93 | apoptotic cell clearance (GO:0043277) | 2.69919789 |
| 94 | axon ensheathment in central nervous system (GO:0032291) | 2.69012098 |
| 95 | central nervous system myelination (GO:0022010) | 2.69012098 |
| 96 | exploration behavior (GO:0035640) | 2.67086975 |
| 97 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.67023411 |
| 98 | polysaccharide catabolic process (GO:0000272) | 2.66932882 |
| 99 | actin filament-based movement (GO:0030048) | 2.66835084 |
| 100 | plasma membrane repair (GO:0001778) | 2.65952484 |
| 101 | peptide catabolic process (GO:0043171) | 2.65415937 |
| 102 | positive regulation of receptor recycling (GO:0001921) | 2.64579771 |
| 103 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.63885532 |
| 104 | neuron-neuron synaptic transmission (GO:0007270) | 2.63676355 |
| 105 | proline transport (GO:0015824) | 2.63579367 |
| 106 | establishment of mitochondrion localization (GO:0051654) | 2.63557529 |
| 107 | nerve growth factor signaling pathway (GO:0038180) | 2.63489637 |
| 108 | intracellular lipid transport (GO:0032365) | 2.61692510 |
| 109 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.60867032 |
| 110 | cell migration in hindbrain (GO:0021535) | 2.60715959 |
| 111 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.60500733 |
| 112 | activation of protein kinase A activity (GO:0034199) | 2.60168194 |
| 113 | response to auditory stimulus (GO:0010996) | 2.60053936 |
| 114 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.59999643 |
| 115 | positive regulation of synapse maturation (GO:0090129) | 2.56578420 |
| 116 | regulation of leukocyte degranulation (GO:0043300) | 2.56516096 |
| 117 | potassium ion import (GO:0010107) | 2.54877681 |
| 118 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.54049252 |
| 119 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.53979538 |
| 120 | long-term memory (GO:0007616) | 2.53699223 |
| 121 | barbed-end actin filament capping (GO:0051016) | 2.53397416 |
| 122 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.53123223 |
| 123 | behavioral response to cocaine (GO:0048148) | 2.52891497 |
| 124 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.52441567 |
| 125 | macroautophagy (GO:0016236) | 2.52370520 |
| 126 | COPII vesicle coating (GO:0048208) | 2.49495987 |
| 127 | cell communication by electrical coupling (GO:0010644) | 2.49170566 |
| 128 | cellular response to arsenic-containing substance (GO:0071243) | 2.49150405 |
| 129 | regulation of sequestering of triglyceride (GO:0010889) | 2.48000964 |
| 130 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.47870992 |
| 131 | neutrophil mediated immunity (GO:0002446) | 2.47842336 |
| 132 | epithelial cell-cell adhesion (GO:0090136) | 2.47389390 |
| 133 | detection of other organism (GO:0098543) | 2.45310483 |
| 134 | neurotransmitter transport (GO:0006836) | 2.45274049 |
| 135 | alpha-linolenic acid metabolic process (GO:0036109) | 2.45248481 |
| 136 | pinocytosis (GO:0006907) | 2.44814962 |
| 137 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.44700349 |
| 138 | skeletal muscle tissue regeneration (GO:0043403) | 2.44208598 |
| 139 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.43122805 |
| 140 | regulation of early endosome to late endosome transport (GO:2000641) | 2.42485978 |
| 141 | regulation of synaptic plasticity (GO:0048167) | 2.42376221 |
| 142 | negative regulation of interleukin-17 production (GO:0032700) | 2.41574220 |
| 143 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.41282708 |
| 144 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.41168936 |
| 145 | regulation of mast cell degranulation (GO:0043304) | 2.40604229 |
| 146 | detection of biotic stimulus (GO:0009595) | 2.40516988 |
| 147 | positive regulation of cholesterol efflux (GO:0010875) | 2.40503725 |
| 148 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.40336502 |
| 149 | regulation of neurotransmitter levels (GO:0001505) | 2.39693900 |
| 150 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.38058496 |
| 151 | positive regulation of regulated secretory pathway (GO:1903307) | 2.37761615 |
| 152 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.37136810 |
| 153 | auditory behavior (GO:0031223) | 2.36785518 |
| 154 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.35622887 |
| 155 | response to nerve growth factor (GO:1990089) | 2.35622887 |
| 156 | glycine transport (GO:0015816) | 2.35400539 |
| 157 | embryonic process involved in female pregnancy (GO:0060136) | 2.35230059 |
| 158 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.33812972 |
| 159 | transmission of nerve impulse (GO:0019226) | 2.32661900 |
| 160 | regulation of female receptivity (GO:0045924) | 2.32598143 |
| 161 | response to host (GO:0075136) | 2.32303485 |
| 162 | response to host defenses (GO:0052200) | 2.32303485 |
| 163 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.32303485 |
| 164 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.32070118 |
| 165 | response to host immune response (GO:0052572) | 2.32025201 |
| 166 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.32025201 |
| 167 | amino acid import (GO:0043090) | 2.31642754 |
| 168 | adult walking behavior (GO:0007628) | 2.31546281 |
| 169 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.31441633 |
| 170 | positive regulation of mast cell degranulation (GO:0043306) | 2.31441633 |
| 171 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.31170173 |
| 172 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.30986336 |
| 173 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.30838366 |
| 174 | negative regulation of amino acid transport (GO:0051956) | 2.30695675 |
| 175 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.30086304 |
| 176 | alanine transport (GO:0032328) | 2.29596246 |
| 177 | neurotransmitter catabolic process (GO:0042135) | 2.27727508 |
| 178 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.27701666 |
| 179 | cellular sodium ion homeostasis (GO:0006883) | 2.27638695 |
| 180 | long term synaptic depression (GO:0060292) | 2.27596071 |
| 181 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.27339763 |
| 182 | presynaptic membrane assembly (GO:0097105) | 2.26684369 |
| 183 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.26446613 |
| 184 | organelle transport along microtubule (GO:0072384) | 2.25817917 |
| 185 | neuromuscular process (GO:0050905) | 2.25629874 |
| 186 | regulation of vesicle fusion (GO:0031338) | 2.24791862 |
| 187 | cell communication involved in cardiac conduction (GO:0086065) | 2.23871791 |
| 188 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.23295933 |
| 189 | mitochondrion transport along microtubule (GO:0047497) | 2.23295933 |
| 190 | mating behavior (GO:0007617) | 2.23087440 |
| 191 | acidic amino acid transport (GO:0015800) | 2.21723686 |
| 192 | creatine metabolic process (GO:0006600) | 2.21624978 |
| 193 | L-glutamate transport (GO:0015813) | 2.20398191 |
| 194 | regulation of neurotransmitter secretion (GO:0046928) | 2.20370728 |
| 195 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.19983952 |
| 196 | regulation of dendritic spine development (GO:0060998) | 2.18727176 |
| 197 | negative regulation of macroautophagy (GO:0016242) | 2.18577519 |
| 198 | axon extension (GO:0048675) | 2.18450893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.88857386 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.09872247 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.09343138 |
| 4 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.94230042 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.92488758 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65877708 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.57230880 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.46554038 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35108858 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.33248527 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.32827966 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.32827966 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31117541 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29053406 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.25176305 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.20756238 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.18193245 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18024693 |
| 19 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.16325210 |
| 20 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.16325210 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.12561970 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.11055692 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08387181 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.08327953 |
| 25 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.06955659 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.06563052 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.05714705 |
| 28 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.01727245 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.00003374 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95769460 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.94593095 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.89700121 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.89639630 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.87302329 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.84442133 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.83862014 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.83600361 |
| 38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83582715 |
| 39 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.82941051 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.81926100 |
| 41 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.79582863 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.76166038 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.71855649 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69142771 |
| 45 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.68790664 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65363066 |
| 47 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62749188 |
| 48 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62457640 |
| 49 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58210220 |
| 50 | CJUN_26792858_Chip-Seq_BT549_Human | 1.56921226 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55496302 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53666957 |
| 53 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.52018019 |
| 54 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.52018019 |
| 55 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.51837062 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51459779 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49407004 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48989735 |
| 59 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47953628 |
| 60 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.47797791 |
| 61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.47549922 |
| 62 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47512820 |
| 63 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.47476474 |
| 64 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.45859548 |
| 65 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44689459 |
| 66 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44669896 |
| 67 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43872593 |
| 68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42447895 |
| 69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42373582 |
| 70 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.42025277 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41561665 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40761090 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40625405 |
| 74 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39235072 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38151104 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35900984 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35320150 |
| 78 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32668078 |
| 79 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.31488223 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.30691331 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29177223 |
| 82 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.28466009 |
| 83 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28286292 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28124926 |
| 85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28008428 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27924928 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.27581384 |
| 88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26030825 |
| 89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.24992005 |
| 90 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24407499 |
| 91 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23649734 |
| 92 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.23330208 |
| 93 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.23296765 |
| 94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23247153 |
| 95 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23167681 |
| 96 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.22801246 |
| 97 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.21391083 |
| 98 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20866546 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20772551 |
| 100 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20495525 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20205796 |
| 102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19200484 |
| 103 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19059169 |
| 104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18736266 |
| 105 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18115944 |
| 106 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18065146 |
| 107 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15928130 |
| 108 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14879009 |
| 109 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.13512448 |
| 110 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13462301 |
| 111 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12385125 |
| 112 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11593724 |
| 113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11550325 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10719479 |
| 115 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09439370 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08986434 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08986434 |
| 118 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08787556 |
| 119 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08065160 |
| 120 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07754362 |
| 121 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07188001 |
| 122 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06916892 |
| 123 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06812571 |
| 124 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05974566 |
| 125 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05817454 |
| 126 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05414259 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03833162 |
| 128 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.03763600 |
| 129 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03209651 |
| 130 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02069272 |
| 131 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02052389 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.01318261 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01076864 |
| 134 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00800709 |
| 135 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00608996 |
| 136 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00202188 |
| 137 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.00067005 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99397959 |
| 139 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98772021 |
| 140 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98573648 |
| 141 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98533343 |
| 142 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.98490454 |
| 143 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98323747 |
| 144 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97684583 |
| 145 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95630925 |
| 146 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95371401 |
| 147 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.94885028 |
| 148 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94267193 |
| 149 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.94131474 |
| 150 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94111896 |
| 151 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93289802 |
| 152 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93062413 |
| 153 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92876723 |
| 154 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92711260 |
| 155 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92341545 |
| 156 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90512082 |
| 157 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.89983593 |
| 158 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89596052 |
| 159 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89207453 |
| 160 | AR_19668381_ChIP-Seq_PC3_Human | 0.88539469 |
| 161 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88272424 |
| 162 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.88194721 |
| 163 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.87887127 |
| 164 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87158768 |
| 165 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86627031 |
| 166 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85333651 |
| 167 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.85060596 |
| 168 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85022121 |
| 169 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84994882 |
| 170 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84579111 |
| 171 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84494945 |
| 172 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83602631 |
| 173 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83425365 |
| 174 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82334812 |
| 175 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82210536 |
| 176 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81632018 |
| 177 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81553073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.13308169 |
| 2 | MP0003880_abnormal_central_pattern | 3.55588678 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.42399037 |
| 4 | MP0004270_analgesia | 3.39885566 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.36538912 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.21428941 |
| 7 | MP0003329_amyloid_beta_deposits | 2.85033177 |
| 8 | MP0003828_pulmonary_edema | 2.72731309 |
| 9 | MP0002064_seizures | 2.61985736 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.58242493 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.55549121 |
| 12 | MP0009745_abnormal_behavioral_response | 2.54505077 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.54480462 |
| 14 | MP0004858_abnormal_nervous_system | 2.45326320 |
| 15 | MP0009046_muscle_twitch | 2.38467304 |
| 16 | MP0002796_impaired_skin_barrier | 2.36660155 |
| 17 | MP0004233_abnormal_muscle_weight | 2.32389274 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.31876328 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.29247446 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.29156527 |
| 21 | MP0003453_abnormal_keratinocyte_physiol | 2.24731880 |
| 22 | MP0003690_abnormal_glial_cell | 2.14857036 |
| 23 | MP0000751_myopathy | 2.10479423 |
| 24 | MP0009840_abnormal_foam_cell | 2.09973508 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.08720224 |
| 26 | MP0002733_abnormal_thermal_nociception | 2.05309277 |
| 27 | MP0001486_abnormal_startle_reflex | 2.02660575 |
| 28 | MP0002572_abnormal_emotion/affect_behav | 2.01682284 |
| 29 | MP0000604_amyloidosis | 2.01019343 |
| 30 | MP0002822_catalepsy | 1.99660677 |
| 31 | MP0000920_abnormal_myelination | 1.99020923 |
| 32 | MP0002272_abnormal_nervous_system | 1.98617876 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.96363072 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.93537132 |
| 35 | MP0003941_abnormal_skin_development | 1.92753338 |
| 36 | MP0003646_muscle_fatigue | 1.91859334 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.89162667 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.88362215 |
| 39 | MP0000778_abnormal_nervous_system | 1.85762519 |
| 40 | MP0001970_abnormal_pain_threshold | 1.85049647 |
| 41 | MP0004130_abnormal_muscle_cell | 1.83167059 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.82857582 |
| 43 | MP0003724_increased_susceptibility_to | 1.81254727 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.80598289 |
| 45 | MP0005409_darkened_coat_color | 1.80473917 |
| 46 | MP0004885_abnormal_endolymph | 1.68266235 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.59079694 |
| 48 | MP0000750_abnormal_muscle_regeneration | 1.58177850 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.57155451 |
| 50 | MP0008004_abnormal_stomach_pH | 1.56964463 |
| 51 | MP0000747_muscle_weakness | 1.56194470 |
| 52 | MP0004510_myositis | 1.56031988 |
| 53 | MP0002254_reproductive_system_inflammat | 1.55646395 |
| 54 | MP0003075_altered_response_to | 1.53155390 |
| 55 | MP0008260_abnormal_autophagy | 1.49091350 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.48966704 |
| 57 | MP0003303_peritoneal_inflammation | 1.46654776 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.46042246 |
| 59 | MP0000383_abnormal_hair_follicle | 1.45573941 |
| 60 | MP0003436_decreased_susceptibility_to | 1.38711212 |
| 61 | MP0003634_abnormal_glial_cell | 1.38649585 |
| 62 | MP0003950_abnormal_plasma_membrane | 1.38403555 |
| 63 | MP0003633_abnormal_nervous_system | 1.38105971 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 1.38080350 |
| 65 | MP0002736_abnormal_nociception_after | 1.36240141 |
| 66 | MP0006082_CNS_inflammation | 1.34798493 |
| 67 | MP0000579_abnormal_nail_morphology | 1.34695517 |
| 68 | MP0001216_abnormal_epidermal_layer | 1.33690880 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 1.30714747 |
| 70 | MP0005386_behavior/neurological_phenoty | 1.29992777 |
| 71 | MP0004924_abnormal_behavior | 1.29992777 |
| 72 | MP0002896_abnormal_bone_mineralization | 1.29971853 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.29577553 |
| 74 | MP0000955_abnormal_spinal_cord | 1.28185275 |
| 75 | MP0000759_abnormal_skeletal_muscle | 1.27982922 |
| 76 | MP0005248_abnormal_Harderian_gland | 1.27935549 |
| 77 | MP0003448_altered_tumor_morphology | 1.27477713 |
| 78 | MP0005058_abnormal_lysosome_morphology | 1.25895740 |
| 79 | MP0002060_abnormal_skin_morphology | 1.25873224 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.25088107 |
| 81 | MP0001905_abnormal_dopamine_level | 1.24996086 |
| 82 | MP0005275_abnormal_skin_tensile | 1.24584455 |
| 83 | MP0003091_abnormal_cell_migration | 1.24564462 |
| 84 | MP0002184_abnormal_innervation | 1.23994382 |
| 85 | MP0008569_lethality_at_weaning | 1.22912629 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 1.22233780 |
| 87 | MP0002419_abnormal_innate_immunity | 1.21811306 |
| 88 | MP0003631_nervous_system_phenotype | 1.21406873 |
| 89 | MP0004811_abnormal_neuron_physiology | 1.21019240 |
| 90 | MP0005023_abnormal_wound_healing | 1.19215170 |
| 91 | MP0005535_abnormal_body_temperature | 1.19002493 |
| 92 | MP0003183_abnormal_peptide_metabolism | 1.18722549 |
| 93 | MP0000733_abnormal_muscle_development | 1.18704975 |
| 94 | MP0004947_skin_inflammation | 1.15574560 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 1.14685721 |
| 96 | MP0002139_abnormal_hepatobiliary_system | 1.13922193 |
| 97 | MP0005164_abnormal_response_to | 1.13414279 |
| 98 | MP0004084_abnormal_cardiac_muscle | 1.13283371 |
| 99 | MP0002882_abnormal_neuron_morphology | 1.12640563 |
| 100 | MP0006138_congestive_heart_failure | 1.11287793 |
| 101 | MP0000858_altered_metastatic_potential | 1.10949023 |
| 102 | MP0004036_abnormal_muscle_relaxation | 1.10826907 |
| 103 | MP0001533_abnormal_skeleton_physiology | 1.08819371 |
| 104 | MP0001502_abnormal_circadian_rhythm | 1.08478762 |
| 105 | MP0004484_altered_response_of | 1.08045589 |
| 106 | MP0003137_abnormal_impulse_conducting | 1.07182072 |
| 107 | MP0005501_abnormal_skin_physiology | 1.05074553 |
| 108 | MP0006054_spinal_hemorrhage | 1.04854759 |
| 109 | MP0005360_urolithiasis | 1.04409296 |
| 110 | MP0001915_intracranial_hemorrhage | 1.03965987 |
| 111 | MP0001853_heart_inflammation | 1.01855178 |
| 112 | MP0003879_abnormal_hair_cell | 1.01551273 |
| 113 | MP0005085_abnormal_gallbladder_physiolo | 1.00283460 |
| 114 | MP0003632_abnormal_nervous_system | 1.00039843 |
| 115 | MP0000343_altered_response_to | 0.98083458 |
| 116 | MP0005451_abnormal_body_composition | 0.97719934 |
| 117 | MP0005076_abnormal_cell_differentiation | 0.97706208 |
| 118 | MP0004142_abnormal_muscle_tone | 0.97606662 |
| 119 | MP0004215_abnormal_myocardial_fiber | 0.97272549 |
| 120 | MP0000377_abnormal_hair_follicle | 0.97009451 |
| 121 | MP0005620_abnormal_muscle_contractility | 0.96121014 |
| 122 | MP0010329_abnormal_lipoprotein_level | 0.95958907 |
| 123 | MP0005645_abnormal_hypothalamus_physiol | 0.95851606 |
| 124 | MP0002148_abnormal_hypersensitivity_rea | 0.95681428 |
| 125 | MP0004742_abnormal_vestibular_system | 0.95664864 |
| 126 | MP0005257_abnormal_intraocular_pressure | 0.95529497 |
| 127 | MP0004272_abnormal_basement_membrane | 0.95371484 |
| 128 | MP0002098_abnormal_vibrissa_morphology | 0.95029159 |
| 129 | MP0008874_decreased_physiological_sensi | 0.94432255 |
| 130 | MP0008438_abnormal_cutaneous_collagen | 0.92222652 |
| 131 | MP0002118_abnormal_lipid_homeostasis | 0.92169286 |
| 132 | MP0002106_abnormal_muscle_physiology | 0.92162059 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.92076242 |
| 134 | MP0005330_cardiomyopathy | 0.91923800 |
| 135 | MP0005369_muscle_phenotype | 0.91916649 |
| 136 | MP0002557_abnormal_social/conspecific_i | 0.90749381 |
| 137 | MP0010630_abnormal_cardiac_muscle | 0.90741960 |
| 138 | MP0002229_neurodegeneration | 0.89124480 |
| 139 | MP0004087_abnormal_muscle_fiber | 0.87452198 |
| 140 | MP0001849_ear_inflammation | 0.87171710 |
| 141 | MP0002876_abnormal_thyroid_physiology | 0.85305175 |
| 142 | MP0001984_abnormal_olfaction | 0.84655939 |
| 143 | MP0000749_muscle_degeneration | 0.84587277 |
| 144 | MP0002090_abnormal_vision | 0.83573072 |
| 145 | MP0002971_abnormal_brown_adipose | 0.83561548 |
| 146 | MP0002269_muscular_atrophy | 0.82970648 |
| 147 | MP0000427_abnormal_hair_cycle | 0.82750985 |
| 148 | MP0005332_abnormal_amino_acid | 0.82182007 |
| 149 | MP0000569_abnormal_digit_pigmentation | 0.82134222 |
| 150 | MP0004085_abnormal_heartbeat | 0.81679716 |
| 151 | MP0005166_decreased_susceptibility_to | 0.81293685 |
| 152 | MP0005365_abnormal_bile_salt | 0.80724198 |
| 153 | MP0002332_abnormal_exercise_endurance | 0.80085077 |
| 154 | MP0001177_atelectasis | 0.78635235 |
| 155 | MP0003172_abnormal_lysosome_physiology | 0.78290686 |
| 156 | MP0002152_abnormal_brain_morphology | 0.77990294 |
| 157 | MP0005319_abnormal_enzyme/_coenzyme | 0.77862698 |
| 158 | MP0005165_increased_susceptibility_to | 0.77361948 |
| 159 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77209149 |
| 160 | MP0004883_abnormal_blood_vessel | 0.76298363 |
| 161 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75847901 |
| 162 | MP0002972_abnormal_cardiac_muscle | 0.75468522 |
| 163 | MP0003195_calcinosis | 0.74474924 |
| 164 | MP0001299_abnormal_eye_distance/ | 0.73522301 |
| 165 | MP0004264_abnormal_extraembryonic_tissu | 0.72723231 |
| 166 | MP0009785_altered_susceptibility_to | 0.72682296 |
| 167 | MP0008057_abnormal_DNA_replication | 0.72590164 |
| 168 | MP0009764_decreased_sensitivity_to | 0.72467075 |
| 169 | MP0001542_abnormal_bone_strength | 0.72376517 |
| 170 | MP0000762_abnormal_tongue_morphology | 0.71160619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 5.43702286 |
| 2 | Focal motor seizures (HP:0011153) | 5.20945637 |
| 3 | Neurofibrillary tangles (HP:0002185) | 4.38305124 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.35759573 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.35759573 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.35759573 |
| 7 | Myokymia (HP:0002411) | 4.34827871 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 4.26539183 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.75820905 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 3.73456040 |
| 11 | Focal seizures (HP:0007359) | 3.67301419 |
| 12 | Mutism (HP:0002300) | 3.46424224 |
| 13 | Distal lower limb muscle weakness (HP:0009053) | 3.45212954 |
| 14 | Asymmetric septal hypertrophy (HP:0001670) | 3.24302216 |
| 15 | Ankle clonus (HP:0011448) | 3.22229182 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.21448130 |
| 17 | Action tremor (HP:0002345) | 3.19976390 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.15872473 |
| 19 | Visual hallucinations (HP:0002367) | 3.15321678 |
| 20 | Exercise-induced myalgia (HP:0003738) | 3.09246615 |
| 21 | Muscle fiber splitting (HP:0003555) | 3.04806938 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.03240218 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 2.98217898 |
| 24 | Eczematoid dermatitis (HP:0000976) | 2.96413507 |
| 25 | Abnormality of the corticospinal tract (HP:0002492) | 2.95643133 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 2.93735740 |
| 27 | Hyperglycinemia (HP:0002154) | 2.82616690 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 2.81835665 |
| 29 | Ventricular fibrillation (HP:0001663) | 2.81513482 |
| 30 | Atonic seizures (HP:0010819) | 2.81505748 |
| 31 | Dysmetria (HP:0001310) | 2.78743674 |
| 32 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.77409280 |
| 33 | Subaortic stenosis (HP:0001682) | 2.77409280 |
| 34 | Distal arthrogryposis (HP:0005684) | 2.77337171 |
| 35 | Frequent falls (HP:0002359) | 2.71051237 |
| 36 | Dialeptic seizures (HP:0011146) | 2.70296433 |
| 37 | Absence seizures (HP:0002121) | 2.69189903 |
| 38 | Malnutrition (HP:0004395) | 2.68967293 |
| 39 | Epileptic encephalopathy (HP:0200134) | 2.67656696 |
| 40 | Insidious onset (HP:0003587) | 2.66260991 |
| 41 | Termporal pattern (HP:0011008) | 2.66260991 |
| 42 | Disinhibition (HP:0000734) | 2.65644939 |
| 43 | Bundle branch block (HP:0011710) | 2.61349701 |
| 44 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.60682013 |
| 45 | Urinary urgency (HP:0000012) | 2.58529723 |
| 46 | Abnormal eating behavior (HP:0100738) | 2.57814693 |
| 47 | Increased connective tissue (HP:0009025) | 2.55950676 |
| 48 | Polyphagia (HP:0002591) | 2.53297623 |
| 49 | Pheochromocytoma (HP:0002666) | 2.53263993 |
| 50 | Genetic anticipation (HP:0003743) | 2.53209685 |
| 51 | Rhabdomyolysis (HP:0003201) | 2.49279386 |
| 52 | Excessive salivation (HP:0003781) | 2.49100436 |
| 53 | Drooling (HP:0002307) | 2.49100436 |
| 54 | Recurrent abscess formation (HP:0002722) | 2.48971901 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48287752 |
| 56 | Loss of speech (HP:0002371) | 2.47037901 |
| 57 | Calf muscle hypertrophy (HP:0008981) | 2.46595632 |
| 58 | Broad-based gait (HP:0002136) | 2.46237629 |
| 59 | Osteolytic defects of the hand bones (HP:0009699) | 2.45590920 |
| 60 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45590920 |
| 61 | Impaired social interactions (HP:0000735) | 2.45167935 |
| 62 | Abnormal social behavior (HP:0012433) | 2.45167935 |
| 63 | Myocardial infarction (HP:0001658) | 2.43690211 |
| 64 | Hyperventilation (HP:0002883) | 2.43011762 |
| 65 | Thick nail (HP:0001805) | 2.41204033 |
| 66 | Neck muscle weakness (HP:0000467) | 2.40659210 |
| 67 | Abnormality of the calf musculature (HP:0001430) | 2.39110588 |
| 68 | Spastic tetraparesis (HP:0001285) | 2.37626340 |
| 69 | Difficulty running (HP:0009046) | 2.36608759 |
| 70 | Intention tremor (HP:0002080) | 2.36295176 |
| 71 | Spastic gait (HP:0002064) | 2.36200680 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.34831077 |
| 73 | Tetraparesis (HP:0002273) | 2.33468886 |
| 74 | Abnormality of the Achilles tendon (HP:0005109) | 2.30142357 |
| 75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.30118843 |
| 76 | Atrioventricular block (HP:0001678) | 2.29769402 |
| 77 | Achilles tendon contracture (HP:0001771) | 2.29736563 |
| 78 | Sudden death (HP:0001699) | 2.27758383 |
| 79 | Myoglobinuria (HP:0002913) | 2.27453668 |
| 80 | Ulnar deviation of the wrist (HP:0003049) | 2.24061700 |
| 81 | Lower limb muscle weakness (HP:0007340) | 2.23263194 |
| 82 | Febrile seizures (HP:0002373) | 2.22695982 |
| 83 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.22113757 |
| 84 | Hemiparesis (HP:0001269) | 2.22043509 |
| 85 | Postural instability (HP:0002172) | 2.21551179 |
| 86 | Abnormality of glycine metabolism (HP:0010895) | 2.21358200 |
| 87 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21358200 |
| 88 | Syncope (HP:0001279) | 2.20871619 |
| 89 | Dysdiadochokinesis (HP:0002075) | 2.19820131 |
| 90 | Hyporeflexia of lower limbs (HP:0002600) | 2.16998979 |
| 91 | Myopathic facies (HP:0002058) | 2.16365486 |
| 92 | Cerebral hemorrhage (HP:0001342) | 2.16110490 |
| 93 | Mitral stenosis (HP:0001718) | 2.15827727 |
| 94 | Progressive inability to walk (HP:0002505) | 2.15397753 |
| 95 | Axonal loss (HP:0003447) | 2.14740135 |
| 96 | Poor eye contact (HP:0000817) | 2.13368108 |
| 97 | Megalencephaly (HP:0001355) | 2.13050681 |
| 98 | Hyperglycinuria (HP:0003108) | 2.11064363 |
| 99 | Papillary thyroid carcinoma (HP:0002895) | 2.10999788 |
| 100 | Vertebral compression fractures (HP:0002953) | 2.10746835 |
| 101 | Akinesia (HP:0002304) | 2.10383037 |
| 102 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.08620543 |
| 103 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.08620543 |
| 104 | Atrophic scars (HP:0001075) | 2.07899027 |
| 105 | Distal lower limb amyotrophy (HP:0008944) | 2.07353211 |
| 106 | Diplopia (HP:0000651) | 2.07320948 |
| 107 | Abnormality of binocular vision (HP:0011514) | 2.07320948 |
| 108 | Clumsiness (HP:0002312) | 2.05270859 |
| 109 | Round ear (HP:0100830) | 2.05240929 |
| 110 | Rapidly progressive (HP:0003678) | 2.05006690 |
| 111 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04479314 |
| 112 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04479314 |
| 113 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04479314 |
| 114 | Neuroendocrine neoplasm (HP:0100634) | 2.04101158 |
| 115 | Scanning speech (HP:0002168) | 2.03382903 |
| 116 | Subacute progressive viral hepatitis (HP:0006572) | 2.01805508 |
| 117 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.01081543 |
| 118 | EMG: myopathic abnormalities (HP:0003458) | 2.00825641 |
| 119 | Mucopolysacchariduria (HP:0008155) | 2.00306480 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00306480 |
| 121 | Status epilepticus (HP:0002133) | 2.00116968 |
| 122 | Heart block (HP:0012722) | 1.99543530 |
| 123 | Hypoalphalipoproteinemia (HP:0003233) | 1.97450423 |
| 124 | Torticollis (HP:0000473) | 1.97300908 |
| 125 | Ventricular tachycardia (HP:0004756) | 1.94661265 |
| 126 | Milia (HP:0001056) | 1.94222659 |
| 127 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.94044522 |
| 128 | Short nail (HP:0001799) | 1.94022794 |
| 129 | Hyperlipoproteinemia (HP:0010980) | 1.93713505 |
| 130 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93518343 |
| 131 | Complement deficiency (HP:0004431) | 1.93223154 |
| 132 | Exercise-induced muscle cramps (HP:0003710) | 1.92985295 |
| 133 | Generalized myoclonic seizures (HP:0002123) | 1.92765913 |
| 134 | Xanthomatosis (HP:0000991) | 1.92033466 |
| 135 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90640809 |
| 136 | Amyloidosis (HP:0011034) | 1.90291583 |
| 137 | Onion bulb formation (HP:0003383) | 1.90217530 |
| 138 | Neuronal loss in central nervous system (HP:0002529) | 1.89731809 |
| 139 | Deep venous thrombosis (HP:0002625) | 1.89006411 |
| 140 | Fetal akinesia sequence (HP:0001989) | 1.88777868 |
| 141 | Areflexia of lower limbs (HP:0002522) | 1.88011562 |
| 142 | Hemiplegia (HP:0002301) | 1.87825810 |
| 143 | Global brain atrophy (HP:0002283) | 1.87472469 |
| 144 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.87287374 |
| 145 | Curly hair (HP:0002212) | 1.87217563 |
| 146 | Abnormal atrioventricular conduction (HP:0005150) | 1.87100511 |
| 147 | Muscle fiber inclusion bodies (HP:0100299) | 1.87015912 |
| 148 | Flat acetabular roof (HP:0003180) | 1.86046139 |
| 149 | Anxiety (HP:0000739) | 1.84945355 |
| 150 | Amblyopia (HP:0000646) | 1.84601453 |
| 151 | Bulbar palsy (HP:0001283) | 1.84344866 |
| 152 | Clonus (HP:0002169) | 1.83411913 |
| 153 | Delusions (HP:0000746) | 1.82739681 |
| 154 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.82161805 |
| 155 | Increased cerebral lipofuscin (HP:0011813) | 1.80665397 |
| 156 | Rigidity (HP:0002063) | 1.79868631 |
| 157 | Inability to walk (HP:0002540) | 1.79571146 |
| 158 | Difficulty climbing stairs (HP:0003551) | 1.78991553 |
| 159 | Myotonia (HP:0002486) | 1.78795378 |
| 160 | Alopecia of scalp (HP:0002293) | 1.77748682 |
| 161 | Fragile nails (HP:0001808) | 1.76361500 |
| 162 | Plantar hyperkeratosis (HP:0007556) | 1.74794096 |
| 163 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.73184186 |
| 164 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73011653 |
| 165 | Vascular calcification (HP:0004934) | 1.68729617 |
| 166 | Resting tremor (HP:0002322) | 1.68513284 |
| 167 | Hypoplasia of dental enamel (HP:0006297) | 1.67804732 |
| 168 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.67614914 |
| 169 | Cardiovascular calcification (HP:0011915) | 1.65771269 |
| 170 | Pathologic fracture (HP:0002756) | 1.63289660 |
| 171 | Increased CSF protein (HP:0002922) | 1.60355406 |
| 172 | Generalized muscle weakness (HP:0003324) | 1.60020858 |
| 173 | Facial diplegia (HP:0001349) | 1.59456415 |
| 174 | Prolonged neonatal jaundice (HP:0006579) | 1.57268965 |
| 175 | Muscle stiffness (HP:0003552) | 1.56837574 |
| 176 | Cone-rod dystrophy (HP:0000548) | 1.56836769 |
| 177 | Periodontitis (HP:0000704) | 1.55810617 |
| 178 | Ovoid vertebral bodies (HP:0003300) | 1.55288576 |
| 179 | Coarse hair (HP:0002208) | 1.54794091 |
| 180 | Premature loss of primary teeth (HP:0006323) | 1.54738362 |
| 181 | Arterial tortuosity (HP:0005116) | 1.54573189 |
| 182 | Progressive neurologic deterioration (HP:0002344) | 1.53994089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.18428850 |
| 2 | MAP3K9 | 3.53658719 |
| 3 | EPHA4 | 3.47982858 |
| 4 | STK24 | 2.73959929 |
| 5 | RIPK4 | 2.72604376 |
| 6 | NTRK3 | 2.71975601 |
| 7 | PHKG2 | 2.65735738 |
| 8 | PHKG1 | 2.65735738 |
| 9 | MAP3K3 | 2.38041786 |
| 10 | KSR2 | 2.22922085 |
| 11 | PAK6 | 2.22730783 |
| 12 | DAPK2 | 2.21085621 |
| 13 | MAP2K4 | 2.17806488 |
| 14 | TGFBR2 | 2.15151965 |
| 15 | MAP3K4 | 2.12601779 |
| 16 | ARAF | 2.11705272 |
| 17 | PIK3CG | 2.08169209 |
| 18 | MAP2K3 | 2.06063703 |
| 19 | IRAK3 | 1.92880670 |
| 20 | EPHA2 | 1.90836146 |
| 21 | MINK1 | 1.86495948 |
| 22 | NTRK1 | 1.86124972 |
| 23 | NTRK2 | 1.72720490 |
| 24 | MAP2K7 | 1.61304249 |
| 25 | MAP3K14 | 1.60739983 |
| 26 | MST1R | 1.60196337 |
| 27 | LATS2 | 1.52017344 |
| 28 | KSR1 | 1.45526042 |
| 29 | CSK | 1.44616952 |
| 30 | MOS | 1.43254751 |
| 31 | GRK5 | 1.43069087 |
| 32 | BLK | 1.39115136 |
| 33 | STK39 | 1.34544561 |
| 34 | PNCK | 1.33822688 |
| 35 | TRPM7 | 1.32949863 |
| 36 | RIPK1 | 1.32808926 |
| 37 | MAP3K2 | 1.31209144 |
| 38 | CDK5 | 1.28200687 |
| 39 | CAMKK1 | 1.26773326 |
| 40 | MET | 1.26392520 |
| 41 | STK38L | 1.26273292 |
| 42 | GRK7 | 1.26261462 |
| 43 | NEK9 | 1.24884768 |
| 44 | CASK | 1.24000505 |
| 45 | YES1 | 1.22061236 |
| 46 | TYK2 | 1.13626141 |
| 47 | EIF2AK3 | 1.13278394 |
| 48 | DYRK2 | 1.11772756 |
| 49 | IRAK2 | 1.10852625 |
| 50 | TYRO3 | 1.10784094 |
| 51 | IRAK4 | 1.08514166 |
| 52 | BRD4 | 1.07922328 |
| 53 | MST4 | 1.07465744 |
| 54 | PLK2 | 1.06548011 |
| 55 | OXSR1 | 1.05676133 |
| 56 | PKN1 | 1.05474111 |
| 57 | PDPK1 | 1.05264547 |
| 58 | PAK3 | 1.04186824 |
| 59 | MAPK12 | 1.03770671 |
| 60 | PAK4 | 1.01957877 |
| 61 | TRIB3 | 1.00109285 |
| 62 | ERN1 | 0.99733584 |
| 63 | DMPK | 0.99576098 |
| 64 | FGR | 0.99178987 |
| 65 | MUSK | 0.97720744 |
| 66 | STK11 | 0.97499459 |
| 67 | CAMK1D | 0.96856000 |
| 68 | ABL2 | 0.96341696 |
| 69 | LMTK2 | 0.96232549 |
| 70 | CAMK2G | 0.95358247 |
| 71 | STK3 | 0.94650916 |
| 72 | NEK6 | 0.94512065 |
| 73 | OBSCN | 0.94132663 |
| 74 | PINK1 | 0.92818566 |
| 75 | PTK2 | 0.92386140 |
| 76 | CAMK2A | 0.92028093 |
| 77 | DDR2 | 0.90639702 |
| 78 | CDK6 | 0.90592852 |
| 79 | CAMK2B | 0.90589760 |
| 80 | MAP3K6 | 0.89908889 |
| 81 | SIK1 | 0.89769563 |
| 82 | PRKAA2 | 0.89613519 |
| 83 | SGK494 | 0.88840661 |
| 84 | SGK223 | 0.88840661 |
| 85 | MAPK13 | 0.88768875 |
| 86 | TAOK1 | 0.88299073 |
| 87 | CSNK1G2 | 0.88082322 |
| 88 | PBK | 0.87869393 |
| 89 | PDGFRA | 0.87319983 |
| 90 | ICK | 0.87267627 |
| 91 | IRAK1 | 0.86535060 |
| 92 | STK38 | 0.86185989 |
| 93 | MAP3K13 | 0.85122753 |
| 94 | PRKCG | 0.84578396 |
| 95 | SGK2 | 0.83591614 |
| 96 | FES | 0.82862079 |
| 97 | TAOK2 | 0.82830085 |
| 98 | SIK2 | 0.81918661 |
| 99 | PRKD3 | 0.80611101 |
| 100 | PRKCZ | 0.79820463 |
| 101 | MARK2 | 0.78335675 |
| 102 | MAP3K12 | 0.77444331 |
| 103 | RET | 0.76741714 |
| 104 | CAMK1G | 0.76736932 |
| 105 | PRKCE | 0.76125738 |
| 106 | PDGFRB | 0.75669104 |
| 107 | TBK1 | 0.74570608 |
| 108 | MAPK7 | 0.73963010 |
| 109 | TTN | 0.72873936 |
| 110 | CAMK2D | 0.72221134 |
| 111 | FGFR2 | 0.71994427 |
| 112 | ZAP70 | 0.71875821 |
| 113 | AKT3 | 0.71543962 |
| 114 | WNK1 | 0.70990595 |
| 115 | MAP3K5 | 0.69324823 |
| 116 | CHUK | 0.67877528 |
| 117 | PDK2 | 0.66633051 |
| 118 | ACVR1B | 0.65288958 |
| 119 | CDK14 | 0.64878287 |
| 120 | ALK | 0.64693014 |
| 121 | MAP3K1 | 0.64634602 |
| 122 | PDK1 | 0.64253036 |
| 123 | STK10 | 0.60794556 |
| 124 | JAK1 | 0.60750318 |
| 125 | BMPR2 | 0.60290535 |
| 126 | LRRK2 | 0.58705320 |
| 127 | PRPF4B | 0.57726682 |
| 128 | DYRK1A | 0.57509151 |
| 129 | RAF1 | 0.57362930 |
| 130 | SGK1 | 0.57128103 |
| 131 | BRAF | 0.56488977 |
| 132 | EPHB1 | 0.56257193 |
| 133 | CDK15 | 0.55393172 |
| 134 | CDK12 | 0.53341250 |
| 135 | NME1 | 0.53104708 |
| 136 | MATK | 0.52035287 |
| 137 | PRKAA1 | 0.51826655 |
| 138 | ERBB4 | 0.51780130 |
| 139 | LATS1 | 0.51700841 |
| 140 | MTOR | 0.51692910 |
| 141 | CAMKK2 | 0.50963225 |
| 142 | CDK18 | 0.50699301 |
| 143 | BMX | 0.49016902 |
| 144 | SGK3 | 0.48627854 |
| 145 | UHMK1 | 0.48045225 |
| 146 | TNIK | 0.47583081 |
| 147 | MELK | 0.47580652 |
| 148 | CAMK1 | 0.47561310 |
| 149 | DAPK3 | 0.46028819 |
| 150 | CDK9 | 0.45722695 |
| 151 | PTK6 | 0.45234550 |
| 152 | GSK3A | 0.43851235 |
| 153 | MAP2K1 | 0.42946540 |
| 154 | RPS6KA2 | 0.42272328 |
| 155 | CDK11A | 0.41648644 |
| 156 | ERBB3 | 0.41287097 |
| 157 | ROCK2 | 0.40025081 |
| 158 | CSNK1G3 | 0.39961912 |
| 159 | PRKD1 | 0.39687841 |
| 160 | FER | 0.39339882 |
| 161 | FYN | 0.39021631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.73519575 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.68560638 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.37761847 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.25594836 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.21785031 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.11787612 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.02155473 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.93933396 |
| 9 | Amoebiasis_Homo sapiens_hsa05146 | 1.90934045 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.88957635 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85150188 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78957611 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.73409832 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.69911411 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.69534406 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69367548 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.63869814 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.59213530 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.56427507 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.51200803 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.51148775 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.49001436 |
| 23 | Olfactory transduction_Homo sapiens_hsa04740 | 1.46073128 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45420534 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45198618 |
| 26 | Circadian rhythm_Homo sapiens_hsa04710 | 1.43033055 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.40962397 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36229531 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34096319 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.32507152 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.32421885 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31974303 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 1.31254895 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.31128366 |
| 35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.27898579 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.27445709 |
| 37 | Adherens junction_Homo sapiens_hsa04520 | 1.25960832 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24438993 |
| 39 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.23707065 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.23311728 |
| 41 | Thyroid cancer_Homo sapiens_hsa05216 | 1.22790016 |
| 42 | Endometrial cancer_Homo sapiens_hsa05213 | 1.21965482 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21590735 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.20784065 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.20124765 |
| 46 | Long-term depression_Homo sapiens_hsa04730 | 1.18468043 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.17925720 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17901304 |
| 49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.16418835 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 1.12124767 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12066916 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07452489 |
| 53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.06805483 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.06424449 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06323486 |
| 56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05454581 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05344420 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04964357 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04914896 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 1.03114847 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 1.02263680 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01907466 |
| 63 | Malaria_Homo sapiens_hsa05144 | 1.01652086 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01629763 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01091929 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99966756 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 0.99856644 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99807049 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.98528050 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98463517 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97647954 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97434823 |
| 73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96890934 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.96705249 |
| 75 | Cocaine addiction_Homo sapiens_hsa05030 | 0.94100836 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.93551879 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93334875 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.91857161 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.91466333 |
| 80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90926108 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90809867 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.90215461 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.89867858 |
| 84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89655728 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88134349 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87814184 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.87613648 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.87160774 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86118872 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85503782 |
| 91 | Taste transduction_Homo sapiens_hsa04742 | 0.85459176 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85316096 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.85250377 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84020334 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82566357 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.82009932 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81694890 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81283839 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79872502 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78790651 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78141974 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77947128 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77078884 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.77012843 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76710619 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.75912204 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75650762 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75465320 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75057492 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74866625 |
| 111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74849990 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73302695 |
| 113 | Influenza A_Homo sapiens_hsa05164 | 0.71009699 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70416031 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70268632 |
| 116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67760047 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67732032 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65121819 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.64989151 |
| 120 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64938939 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63580510 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63330733 |
| 123 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62176307 |
| 124 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61570327 |
| 125 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60579815 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60483656 |
| 127 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60336713 |
| 128 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60261411 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59758321 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57682484 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.56332898 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56298943 |
| 133 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56157815 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56068060 |
| 135 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56023293 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55934764 |
| 137 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55013629 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.54920963 |
| 139 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54175815 |
| 140 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53513259 |
| 141 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53424704 |
| 142 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53366949 |
| 143 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53321909 |
| 144 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53248981 |
| 145 | Shigellosis_Homo sapiens_hsa05131 | 0.52634206 |
| 146 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52174862 |
| 147 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50817810 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49969005 |
| 149 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49772633 |
| 150 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49350165 |
| 151 | Phagosome_Homo sapiens_hsa04145 | 0.49278139 |
| 152 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.49084438 |
| 153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48685549 |
| 154 | Melanogenesis_Homo sapiens_hsa04916 | 0.48285825 |
| 155 | Platelet activation_Homo sapiens_hsa04611 | 0.47333649 |
| 156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46856465 |
| 157 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46660477 |
| 158 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46406531 |
| 159 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45745142 |
| 160 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45523828 |
| 161 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44527778 |
| 162 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44061105 |
| 163 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43468689 |
| 164 | Peroxisome_Homo sapiens_hsa04146 | 0.43165982 |
| 165 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42716801 |
| 166 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42331081 |
| 167 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42313074 |
| 168 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41773172 |
| 169 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41163766 |
| 170 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40938852 |
| 171 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.40934867 |
| 172 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40644449 |

